Editas Medicine Information
Contact top employees from
Editas Medicine
Summary
Editas Medicine is a public company that has been in the industry for 12 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by James C. Mullen. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 100 to 250. The annual revenue of Editas Medicine varies between 25M and 100M. Total funding of the company - $473M. To connect with Editas Medicine employee register on SignalHire.
Organization Website | editasmedicine.com |
Social Links |    |
Phone Number | 617-401-9000 |
Industries | |
Headquarters Location | 11 Hurley St, Cambridge, Massachusetts, 02141 US |
Employees Size | 200-500 employees |
Specialties | Genome Editing, In Vivo (in body) Editing, Engineered Cell Medicines, Ocular Medicines, Genetic Diseases, Blood Diseases, Sickle Cell Disease, Cancer, Rare Diseases, Immunogenetics, Transfusion-Dependent Beta Thalassemia, Hematopoietic Stem Cells |
SIC Code | 2834 |
DMA Code | Greater Boston |
Founded | 2013 |
Estimated Annual Revenue | $25M - 100M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2016 | Privately Held | 25 - 100 | 6M | $15.6M | |
| 2012 | Privately Held | 25 - 100 | 6.3M | $461.5M | |
| 2013 | Public Company | 250 - 500 | 901.8M | $183M | |
| 2014 | Public Company | 250 - 500 | 41.8M | $883M |
Estimated Website Traffic
The chart shows a decline in traffic to the editasmedicine.com website. In November, traffic decreased to 15973, compared to 16079 in the previous month. The highest traffic in 2025 was recorded in August, reaching 22847 visits.
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Editas Medicine shows a diverse range of experience levels:
1% have been with the company for less than 1 year11% for 1–2 years26% for 3–4 years35% for 5–7 years9% for 8–10 years17% have over 11 years of service at Editas MedicineEx-employees positions
In Company
In New Company
Contact top employees from
Editas Medicine
Preethi Bapna
VP, Corporate Strategy & Communications | Chief of Staff to CEO
Greg Whitehead
Executive Vice President, Chief Technical and Quality Officer
Todd Holman
Sr. Facility Manager
Anila Mehta
Research Associate I
Amanda Erlwein
Clinical Trial Manager
Yasmeen Elaywan
Cell Manufacturing Associate
Cynthia Collins
Chief Executive Officer
Gulum Kosova
Associate Director, Statistical Genetics
Uyen Nguyen
Associate Director of Quality Systems
Frank Panaccio
Chief Business Officer
Linea Aspesi
EVP. Chief Administration Officer
Jianying Shi
Senior Director, R&D IT Business Partner
Parth Amin
Scientist II Molecular Bioanalytics
John Thomas
Senior Director
David Allen
Director, DSPV Operations/Scientist
Ramya Viswanathan
Senior Associate Scientist
Bernadette Connaughton
Board Member
Aayush Agarwal
Associate Scientist
Emem Akpan
Senior Director, External Manufacturing & Supply Chain
Muhammad Haris Jamil
Validation Engineer
Reddy Gangidi Manaswi
CSV Analyst
Ryan Jacob Santosh
Senior Research Associate, LNP Formulation & Targeted Delivery
Similar Companies
FAQ
Editas Medicine operates in the Biotech industries. More details can be found on the official website: editasmedicine.com.
The headquarters of Editas Medicine are located in Cambridge, United States.
The current CEO of Editas Medicine is James C. Mullen
You can contact Editas Medicine by phone at 617-401-9000.
Editas Medicine currently employs 200-500 people.
Editas Medicine's revenue is approximately 97.6M.
Well-known competitors of Editas Medicine include Arbor Biotechnologies, Caribou Biosciences, CRISPR Therapeutics and Intellia Therapeutics, Inc..
